Vanguard Group Inc Tango Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,645,303 shares of TNGX stock, worth $11.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,645,303

Previous 3,294,572 10.65%

Holding current value

$11.1 Million

Previous $28.3 Million 0.7%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.36 - $11.93 $2.58 Million - $4.18 Million	350,731 Added 10.65%	3,645,303 $28.1 Million
Q2 2024 Aug 13, 2024	BUY	$6.66 - $10.15 $1.42 Million - $2.17 Million	213,687 Added 6.94%	3,294,572 $28.3 Million
Q1 2024 May 10, 2024	BUY	$7.51 - $12.88 $763,564 - $1.31 Million	101,673 Added 3.41%	3,080,885 $24.5 Million
Q4 2023 Feb 14, 2024	BUY	$6.52 - $12.01 $256,685 - $472,821	39,369 Added 1.34%	2,979,212 $29.5 Million
Q3 2023 Nov 14, 2023	BUY	$2.93 - $11.26 $579,038 - $2.23 Million	197,624 Added 7.21%	2,939,843 $33.1 Million
Q2 2023 Aug 14, 2023	SELL	$2.67 - $4.7 $20,567 - $36,204	-7,703 Reduced 0.28%	2,742,219 $9.1 Million
Q1 2023 May 15, 2023	BUY	$3.76 - $8.06 $132,013 - $282,986	35,110 Added 1.29%	2,749,922 $10.9 Million
Q4 2022 Feb 10, 2023	BUY	$3.41 - $8.29 $378,741 - $920,753	111,068 Added 4.27%	2,714,812 $19.7 Million
Q3 2022 Nov 14, 2022	SELL	$3.25 - $5.46 $1.33 Million - $2.23 Million	-408,174 Reduced 13.55%	2,603,744 $9.43 Million
Q2 2022 Aug 12, 2022	BUY	$3.86 - $8.01 $1.15 Million - $2.39 Million	297,955 Added 10.98%	3,011,918 $13.6 Million
Q1 2022 May 13, 2022	BUY	$7.01 - $10.94 $8.88 Million - $13.9 Million	1,267,198 Added 87.59%	2,713,963 $20.6 Million
Q4 2021 Feb 14, 2022	BUY	$9.55 - $14.29 $591,517 - $885,108	61,939 Added 4.47%	1,446,765 $15.8 Million
Q3 2021 Nov 12, 2021	BUY	$9.56 - $17.3 $13.2 Million - $24 Million	1,384,826 New	1,384,826 $17.9 Million

Others Institutions Holding TNGX

# of Institutions

123

Shares Held

91.7M

Call Options Held

3.1K

Put Options Held

1.5K

View Full List

About Tango Therapeutics, Inc.

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $268M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

More about TNGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Tango Therapeutics, Inc. Transaction History